Common Contracts
4 similar Asset Purchase Agreement contracts by Insys Therapeutics, Inc.
ASSET PURCHASE AGREEMENT BETWEEN PHARMBIO KOREA, INC. AND INSYS THERAPEUTICS, INC. DATED AS OF SEPTEMBER 25, 2019Asset Purchase Agreement • September 26th, 2019 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New York
other Assigned Patents. All questions concerning the construction, validity and interpretation of this Assignment and the performance of the obligations imposed by this Assignment shall be governed by, and construed in accordance with, the Laws of the State of New York (without regard to the choice of Law principles thereof) and the intellectual property Laws of the United States without giving effect to any Law that would result in the application of a different body of Law than as set forth in this Section 3, except to the extent that such Laws are superseded by the Bankruptcy Code.
ASSET PURCHASE AGREEMENT BETWEEN BTcP PHARMA, LLC, AND INSYS THERAPEUTICS, INC. DATED AS OF September 1, 2019Asset Purchase Agreement • September 3rd, 2019 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of September 1, 2019, is made by and between BTcP Pharma, LLC, a Wyoming limited liability company (“Buyer”), and Insys Therapeutics, Inc., a Delaware corporation (“Seller”). Buyer and Seller are each referred to individually as a “Party” and together as the “Parties”.
ASSET PURCHASE AGREEMENT BETWEEN CHILION GROUP HOLDINGS US, INC. AND INSYS THERAPEUTICS, INC. DATED AS OF AUGUST 6, 2019Asset Purchase Agreement • August 8th, 2019 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New York
ASSET PURCHASE AGREEMENT BETWEEN HIKMA PHARMACEUTICALS USA INC. AND INSYS THERAPEUTICS, INC. DATED AS OF AUGUST 5, 2019Asset Purchase Agreement • August 8th, 2019 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of August 5, 2019, is made by and between Hikma Pharmaceuticals USA Inc., a Delaware corporation (“Buyer”), and Insys Therapeutics, Inc., a Delaware corporation (“Seller”). Buyer and Seller are each referred to individually as a “Party” and together as the “Parties”.
